Feasibility of Transcatheter Aortic Valve Implantation Without Balloon Pre-Dilation A Pilot Study

被引:153
作者
Grube, Eberhard [1 ]
Naber, Christoph [2 ]
Abizaid, Alexandre [3 ]
Sousa, Eduardo [3 ]
Mendiz, Oscar [4 ]
Lemos, Pedro [5 ]
Kalil Filho, Roberto [5 ]
Mangione, Jose [6 ]
Buellesfeld, Lutz [7 ]
机构
[1] Univ Klinikum Bonn, Med Klin & Poliklin 2, Dept Med 2, D-53105 Bonn, Germany
[2] Int Heart Ctr, Essen, Germany
[3] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil
[4] Fdn Favaloro, Buenos Aires, DF, Argentina
[5] Hosp Sirio Libanes, Sao Paulo, Brazil
[6] Hosp Beneficencia Portuguesa, Sao Paulo, Brazil
[7] Univ Hosp Bern, Swiss Cardiovasc Ctr, CH-3010 Bern, Switzerland
关键词
aortic valve stenosis; balloon pre-dilation; transcatheter aortic valve implantation; HIGH-RISK PATIENTS; ELDERLY-PATIENTS; HEART-VALVE; FOLLOW-UP; STENOSIS; PROSTHESIS; VALVULOPLASTY; REPLACEMENT; IMMEDIATE; SUCCESS;
D O I
10.1016/j.jcin.2011.03.015
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objectives The purpose of this pilot study was to evaluate the feasibility and safety of transcatheter aortic valve implantation (TAVI) without balloon pre-dilation. Background Balloon pre-dilation of the stenosed aortic valve is currently believed to be a necessary step for valve preparation before device placement in patients undergoing TAVI and, therefore, is considered an obligatory part of the procedure. However, clear evidence supporting this policy is lacking. In contrast, pre-dilation might be responsible in part for distal embolizations as well as atrioventricular conduction disturbances seen during TAVI procedures. Methods A total of 60 consecutive patients (mean age 80.1 +/- 6.4 years, 53% female, mean logistic Euro Score 23.3 +/- 15.2%) undergoing TAVI using the self-expanding Medtronic Core Valve prosthesis (Medtronic, Minneapolis, Minnesota) have been prospectively enrolled at 13 international centers. Results Pre-procedural mean transaortic valve gradient was 47.8 +/- 15.5 mm Hg, mean effective orifice area was 0.67 +/- 0.15 cm(2). Technical success rate was 96.7% (58 of 60) of patients. Post-dilation was performed in 16.7% (10 of 60) of patients. Post-procedural mean valve gradient was 4.4 +/- 2.0 mm Hg. Circular and noncircular valve configuration was present in 41 and 19 cases (68.3% vs. 31.7%), respectively, with similar effective orifice areas (1.74 +/- 0.10 cm(2) vs. 1.71 +/- 0.22 cm(2), p = NS). In-hospital mortality, myocardial infarction, stroke, and major vascular complications occurred in 6.7% (4 of 60), 0%, 5%, and 10% of patients. There was no valve embolization. New permanent pacing was needed in 11.7% (7 of 60) of patients. Conclusions Transcatheter aortic valve implantation without balloon pre-dilation is feasible and safe, resulting in similar acute safety and efficacy as the current standard approach of TAVI with pre-dilation. (J Am Coll Cardiol Intv 2011;4:751-7) (C) 2011 by the American College of Cardiology Foundation
引用
收藏
页码:751 / 757
页数:7
相关论文
共 21 条
[1]
BASHORE TM, 1991, CIRCULATION, V84, P2383
[2]
2-Year Follow-Up of Patients Undergoing Transcatheter Aortic Valve Implantation Using a Self-Expanding Valve Prosthesis [J].
Buellesfeld, Lutz ;
Gerckens, Ulrich ;
Schuler, Gerhard ;
Bonan, Raoul ;
Kovac, Jan ;
Serruys, Patrick W. ;
Labinaz, Marino ;
den Heijer, Peter ;
Mullen, Michael ;
Tymchak, Wayne ;
Windecker, Stephan ;
Mueller, Ralf ;
Grube, Eberhard .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (16) :1650-1657
[3]
Transcatheter aortic valve implantation: predictors of procedural success-the Siegburg-Bern experience [J].
Buellesfeld, Lutz ;
Wenaweser, Peter ;
Gerckens, Ulrich ;
Mueller, Ralf ;
Sauren, Barthel ;
Latsios, Georg ;
Zickmann, Bernfried ;
Hellige, Gerrit ;
Windecker, Stephan ;
Grube, Eberhard .
EUROPEAN HEART JOURNAL, 2010, 31 (08) :984-991
[4]
Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis [J].
Cribier, A ;
Eltchaninoff, H ;
Tron, C ;
Bauer, F ;
Agatiello, C ;
Sebagh, L ;
Bash, A ;
Nusimovici, D ;
Litzler, PY ;
Bessou, JP ;
Leon, MB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (04) :698-703
[5]
Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis - First human case description [J].
Cribier, A ;
Eltchaninoff, H ;
Bash, A ;
Borenstein, N ;
Tron, C ;
Bauer, F ;
Derumeaux, G ;
Anselme, F ;
Laborde, F ;
Leon, MB .
CIRCULATION, 2002, 106 (24) :3006-3008
[6]
CRIBIER A, 1986, LANCET, V1, P63
[7]
Treatment of calcific aortic stenosis with the percutaneous heart valve - Mid-term follow-up from the initial feasibility studies: The French experience [J].
Cribier, A ;
Eltchaninoff, H ;
Tron, C ;
Bauer, F ;
Agatiello, C ;
Nercolini, D ;
Tapiero, S ;
Litzler, PY ;
Bessou, JP ;
Babaliaros, V .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (06) :1214-1223
[8]
BALLOON AORTIC VALVULOPLASTY IN ELDERLY PATIENTS AT HIGH-RISK FOR SURGERY, OR INOPERABLE - IMMEDIATE AND MID-TERM RESULTS [J].
ELTCHANINOFF, H ;
CRIBIER, A ;
TRON, C ;
ANSELME, F ;
KONING, R ;
SOYER, R ;
LETAC, B .
EUROPEAN HEART JOURNAL, 1995, 16 (08) :1079-1084
[9]
First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve [J].
Grube, E ;
Laborde, JC ;
Zickmann, B ;
Gerckens, U ;
Felderhoff, T ;
Sauren, B ;
Bootsveld, A ;
Buellesfeld, L ;
Iversen, S .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2005, 66 (04) :465-469
[10]
Percutaneous aortic valve replacement for severe aortic stenosis in high-rick patients using the second- and current third-generation self-expanding CoreValve prosthesis - Device success and 30-day clinical outcome [J].
Grube, Eberhard ;
Schuler, Gerhard ;
Buellesfeld, Lutz ;
Gerckens, Ulrich ;
Linke, Axel ;
Wenaweser, Peter ;
Sauren, Barthel ;
Mohr, Friedrich-Wilhelm ;
Walther, Thomas ;
Zickmann, Bernfried ;
Iversen, Stein ;
Felderhoff, Thomas ;
Cartier, Raymond ;
Bonan, Raoul .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (01) :69-76